论文部分内容阅读
心血管疾病很容易发展成慢性心力衰竭,也很容易引起患者死亡。β受体阻滞剂作为一种强效负性肌力药,在临床上有很长一段时间都被禁止用于慢性心力衰竭的治疗。但是,此种药物对于慢性心力衰竭的疗效已经被大量的临床实验证实,并且也已经取得一定的成就。本文着重阐述了β受体阻滞剂在慢性心力衰竭治疗方面的现状、所存在的问题,使用过程中应该注意的基本原则和相关注意事项,并对β受体阻滞剂在慢性心力衰竭临床治疗中的使用前景做出展望。
Cardiovascular disease can easily develop into chronic heart failure, it is also very easy to cause the patient to die. Beta blockers, as a potent negative inotropic agent, have been banned clinically for the treatment of chronic heart failure for a long time. However, the efficacy of this drug in chronic heart failure has been confirmed by a large number of clinical trials and some achievements have been made. This article focuses on the status of β-blockers in the treatment of chronic heart failure, the problems that exist, the use of basic principles and precautions should be noted, and β-blockers in clinical treatment of chronic heart failure Prospects for the use of treatment in the future.